Tag Archives: esrx

CVS Picks Gilead Hep C Drugs As Price War Looms

CVS Health (CVS) on Monday said it would select Gilead Sciences’ (GILD) Sovaldi and Harvoni as the exclusive treatments for hepatitis C patients who use some of its benefit plans, the latest development in what could become a price war among hepatitis C drugmakers. The decision, which takes hold Wednesday, comes after Express Scripts’ (ESRX) move last month to dump Gilead’s drugs from its preferred formulary list for genotype 1 hepatitis C

Express Scripts Picks AbbVie HCV Drugs Over Gilead

Pharmacy benefit manager Express Scripts (ESRX) announced Monday that it’s putting AbbVie’s newly approved hepatitis C treatment on its preferred formulary list and knocking off Gilead Sciences’ rivals. Gilead plunged 13% in morning trading in the stock market today, and AbbVie (ABBV) was down nearly 1%. Late Friday, the FDA approved Viekira Pak, a combination of three novel drugs along with an older product called ritonavir, as the second

How Can Drugmakers Handle New Pricing Pressures?

The subject of drug pricing keeps getting hotter, though for most people it’s a mysterious process. On Nov. 25, pharmacy benefit manager Express Scripts (ESRX) said that to rein in costs it’s upping the number of drugs excluded from its 2015 formulary to 66 from 48, with new targets including